Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/34269
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.contributor.author | Günen, Hakan | - |
dc.contributor.author | Kılınç, Öznur | - |
dc.contributor.author | Polatlı, Mehmet | - |
dc.contributor.author | Suerdem, Mecit | - |
dc.date.accessioned | 2023-10-10T07:54:54Z | - |
dc.date.available | 2023-10-10T07:54:54Z | - |
dc.date.issued | 2016-03-23 | - |
dc.identifier.citation | Günen, H. vd. (2016). "Modification of the GOLD recommendations for chronic obstructive pulmonary disease to broaden their usage in Turkey". Expert Review of Respiratory Medicine, 10(6), 625-628. | en_US |
dc.identifier.issn | 1747-6348 | - |
dc.identifier.issn | 1747-6356 | - |
dc.identifier.uri | https://doi.org/10.1586/17476348.2016.1171146 | - |
dc.identifier.uri | https://www.tandfonline.com/doi/full/10.1586/17476348.2016.1171146 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34269 | - |
dc.description.abstract | Despite the introduction of numerous national and international COPD guidelines designed to provide clinicians with optimal evidence-based disease management strategies, COPD remains an underdiagnosed and poorly treated disease. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend disease specific diagnosis and management strategies, and they are widely used internationally. In this short report we present the outcomes of a meeting of respiratory experts in Turkey who reviewed the GOLD guidelines and their applicability to the Turkish healthcare system. In particular, we were interested to investigate the possibility of developing a simplified version of the combined assessment model which we believe will be more acceptable to Turkish pulmonologists and will increase its use in everyday clinical practice. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Respiratory system | en_US |
dc.subject | Chronic obstructive pulmonary disease | en_US |
dc.subject | COPD diagnosis | en_US |
dc.subject | GOLD guidelines | en_US |
dc.subject | Turkey | en_US |
dc.subject | COPD | en_US |
dc.subject.mesh | Delivery of health care | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Practice guidelines as topic | en_US |
dc.subject.mesh | Pulmonary disease, chronic obstructive | en_US |
dc.subject.mesh | Turkey | en_US |
dc.title | Modification of the GOLD recommendations for chronic obstructive pulmonary disease to broaden their usage in Turkey | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000381046500005 | tr_TR |
dc.identifier.scopus | 2-s2.0-84962920855 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Hastalıkları Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 625 | tr_TR |
dc.identifier.endpage | 628 | tr_TR |
dc.identifier.volume | 10 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Expert Review of Respiratory Medicine | en_US |
dc.contributor.buuauthor | Uzaslan, Esra | - |
dc.contributor.researcherid | CDI-1977-2022 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 27015415 | tr_TR |
dc.subject.wos | Respiratory system | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 8761653500 | tr_TR |
dc.subject.scopus | Undifferentiated Connective Tissue Diseases; Adrenal Cortex Hormone; Global Initiatives | en_US |
dc.subject.emtree | Beta 2 adrenergic receptor stimulating agent | en_US |
dc.subject.emtree | Corticosteroid | en_US |
dc.subject.emtree | Long acting drug | en_US |
dc.subject.emtree | Muscarinic receptor blocking agent | en_US |
dc.subject.emtree | Short acting drug | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Biomass | en_US |
dc.subject.emtree | Chronic obstructive lung disease | en_US |
dc.subject.emtree | Clinical practice | en_US |
dc.subject.emtree | Comorbidity assessment | en_US |
dc.subject.emtree | Evidence based practice | en_US |
dc.subject.emtree | Forced expiratory volume | en_US |
dc.subject.emtree | Forced vital capacity | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Occupational exposure | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Patient assessment | en_US |
dc.subject.emtree | Physical activity | en_US |
dc.subject.emtree | Practice guideline | en_US |
dc.subject.emtree | Pulmonologist | en_US |
dc.subject.emtree | Smoking | en_US |
dc.subject.emtree | Smoking cessation | tr_TR |
dc.subject.emtree | Symptom | tr_TR |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | Vaccination | en_US |
dc.subject.emtree | Health care delivery | en_US |
dc.subject.emtree | Organization and management | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Pulmonary disease, chronicobstructive | en_US |
dc.subject.emtree | Turkey | en_US |
Koleksiyonlarda Görünür: | PubMed Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.